259.8

-1.03%↓

SAN

80.72

+2.25%↑

MRK1

109.9

-0.9%↓

SHL.DE

47.3

-0.55%↓

ARGX

651.8

+0.37%↑

259.8

-1.03%↓

SAN

80.72

+2.25%↑

MRK1

109.9

-0.9%↓

SHL.DE

47.3

-0.55%↓

ARGX

651.8

+0.37%↑

259.8

-1.03%↓

SAN

80.72

+2.25%↑

MRK1

109.9

-0.9%↓

SHL.DE

47.3

-0.55%↓

ARGX

651.8

+0.37%↑

259.8

-1.03%↓

SAN

80.72

+2.25%↑

MRK1

109.9

-0.9%↓

SHL.DE

47.3

-0.55%↓

ARGX

651.8

+0.37%↑

259.8

-1.03%↓

SAN

80.72

+2.25%↑

MRK1

109.9

-0.9%↓

SHL.DE

47.3

-0.55%↓

ARGX

651.8

+0.37%↑

Kodu・Aktsiate loetelu・Vetoquinol SA

Vetoquinol SA

Suletud

SektorTervishoid

72.7 0.28

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

70.8

Max

72.7

Põhinäitajad
By Trading Economics
Sissetulek	35M
Müük	275M
P/E Sektori keskmine	14.619 35.733
Aktsiakasum	2.97
Dividenditootlus	1.19
Kasumimarginaal	12.694
Töötajad	2,437
EBITDA	60M

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	1.19% 3.13%
Järgmine tulemuste avaldamine	11. sept 2025

Turustatistika
By TradingEconomics
Turukapital	870M
Eelmine avamishind	72.42
Eelmine sulgemishind	72.7

Uudiste sentiment

By Acuity

50%

156 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

72.6 / 75.1 Toetus ja vastupanu

Vetoquinol SA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

9. sept 2025, 23:37 UTC

Kuumad aktsiad

Stocks to Watch: Oracle, Wearable Devices, GameStop

9. sept 2025, 20:41 UTC

Tulu

Oracle's Backlog Surges With Major Customer Deals in 1Q

9. sept 2025, 20:30 UTC

Tulu

GameStop 2Q Sales, Profit Rise

9. sept 2025, 23:19 UTC

Market Talk

ANZ Adds a Further 50 Bps in FOMC Cuts to Outlook -- Market Talk

9. sept 2025, 21:35 UTC

Tulu

Oracle Stock Soars on Strong AI Backlog. Earnings Were Good Enough. -- Barrons.com

9. sept 2025, 21:32 UTC

Tulu

Oracle's Backlog Swells With Big Customer Deals -- Update

9. sept 2025, 21:02 UTC

Omandamised, ülevõtmised, äriostud

DHL Adds to Healthcare Logistics Services With Acquisition -- Update

9. sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. sept 2025, 20:33 UTC

Tulu

These Stocks Moved the Most Today: Apple, UnitedHealth, Nebius, Wolfspeed, Tourmaline Bio, Albemarle, Dell, and More -- Barrons.com

9. sept 2025, 20:26 UTC

Tulu

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9. sept 2025, 20:23 UTC

Tulu

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9. sept 2025, 20:12 UTC

Tulu

Oracle Stock Jumps on Mixed Earnings Report -- Barrons.com

9. sept 2025, 20:10 UTC

Tulu

Oracle Expects Cloud Infrastructure Rev to Grow 77% to $18 B This Fiscal Yr >ORCL

9. sept 2025, 20:10 UTC

Tulu

Oracle Expects to Sign-Up Several Additional Multi-B-dollar Customers and RPO Is Likely to Exceed Half-A-Trillion Dollars Over Next Few Mos

9. sept 2025, 20:09 UTC

Tulu

Synopsys Sees 4Q Adj EPS $2.76-Adj EPS $2.80 >SNPS

9. sept 2025, 20:09 UTC

Tulu

Synopsys Sees 4Q Loss/Shr 16c-Loss 27c >SNPS

9. sept 2025, 20:08 UTC

Tulu

Oracle 1Q Short-term Deferred Rev Were $12.1 B >ORCL

9. sept 2025, 20:08 UTC

Tulu

Oracle 1Q Operating Income Was $4.3 B >ORCL

9. sept 2025, 20:08 UTC

Tulu

Oracle Expects MultiCloud Rev to Grow Substantially Every Qtr for Several Years >ORCL

9. sept 2025, 20:08 UTC

Tulu

Synopsys Sees 4Q Rev $2.23B-$2.26B >SNPS

9. sept 2025, 20:07 UTC

Tulu

Oracle Total Remaining Performance Obligations Up to $455 B >ORCL

9. sept 2025, 20:06 UTC

Tulu

Oracle 1Q Software Revenue $5.72B >ORCL

9. sept 2025, 20:06 UTC

Tulu

Synopsys 3Q Adj EPS $3.39 >SNPS

9. sept 2025, 20:06 UTC

Tulu

Oracle 1Q Cloud Revenue $7.19B >ORCL

9. sept 2025, 20:05 UTC

Tulu

Oracle 1Q Rev $14.93B >ORCL

9. sept 2025, 20:05 UTC

Tulu

Oracle 1Q EPS $1.01 >ORCL

9. sept 2025, 20:05 UTC

Tulu

Synopsys 3Q EPS $1.50 >SNPS

9. sept 2025, 20:05 UTC

Tulu

Oracle 1Q Services Revenue $1.35B >ORCL

9. sept 2025, 20:05 UTC

Tulu

Oracle 1Q Adj EPS $1.47 >ORCL

9. sept 2025, 20:05 UTC

Tulu

Oracle 1Q Hardware Revenue $670M >ORCL

Võrdlus sarnastega

Hinnamuutus

Vetoquinol SA Prognoos

Hinnangu Konsensus

By TipRanks

0 ratings

Osta

Hoia

Müü

Põhineb 0 analüütiku instrumendi Vetoquinol SA aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

72.6 / 75.1Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

156 / 371 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.